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Background: The European Society of Cardiology recommends that patients with >10% area of ischemia should
receive revascularization. We investigated inter-observer variability for the extent of ischemic defects reported by
different physicians and by different software tools, and if inter-observer variability was reduced when the physicians
were provided with a computerized suggestion of the defects.
Methods: Twenty-five myocardial perfusion single photon emission computed tomography (SPECT) patients who were
regarded as ischemic according to the final report were included. Eleven physicians in nuclear medicine delineated the
extent of the ischemic defects. After at least two weeks, they delineated the defects again, and were this time provided
a suggestion of the defect delineation by EXINI HeartTM (EXINI). Summed difference scores and ischemic extent values
were obtained from four software programs.
Results: The median extent values obtained from the 11 physicians varied between 8% and 34%, and between 9% and
16% for the software programs. For all 25 patients, mean extent obtained from EXINI was 17.0% (± standard deviation
(SD) 14.6%). Mean extent for physicians was 22.6% (± 15.6%) for the first delineation and 19.1% (± 14.9%) for the
evaluation where they were provided computerized suggestion. Intra-class correlation (ICC) increased from 0.56
(95% confidence interval (CI) 0.41-0.72) to 0.81 (95% CI 0.71-0.90) between the first and the second delineation,
and SD between physicians were 7.8 (first) and 5.9 (second delineation).
Conclusions: There was large variability in the estimated ischemic defect size obtained both from different
physicians and from different software packages. When the physicians were provided with a suggested delineation,
the inter-observer variability decreased significantly.
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Myocardial perfusion scintigraphy (MPS) is widely regarded
as a clinically useful non-invasive imaging method for
the diagnosis of suspected coronary artery disease, iden-
tification of culprit lesions and risk assessment [1-4].
Visual interpretation of MPS studies is dependent on
the knowledge of the physician, and subject to inter- and
intra-observer variability. Software packages for auto-* Correspondence: elin.tragardh@med.lu.se
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distribution, and reproduction in any mediummated quantification of MPS, such as ejection fraction
and summed stress score (SSS), have been developed in
order to make the interpretations more standardized.
Recent studies have shown that patients with signifi-
cant ischemia and without extensive scar were likely to
realize a survival benefit from early revascularization
[3,5]. In contrast, the survival of patients with minimal
ischemia was superior with medical therapy without
early revascularization. Therefore, determination of the
amount of ischemia is essential for patient management.
In the studies, the percent ischemic myocardium was cal-
culated using 5 point/20-segment MPS scoring, i.e. takingntral Ltd. This is an Open Access article distributed under the terms of the
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myocardium. The results from the studies were recently
incorporated into guidelines on revascularization. The
European Society of Cardiology recommends that patients
with stable angina or silent ischemia with “proven large
area of ischemia (>10%)” should receive revascularization
(class 1B) [6].
Several studies have demonstrated that the variability
between different software packages to calculate scoring
values are considerable [7-9], which will affect the calcu-
lated percent ischemic myocardium.
It has previously been shown that referring physicians
to MPS tend to underestimate the extent of ischemia and
infarction reported by the physician in nuclear medicine
[10]. Because of the new recommendations, it is important
to report the amount of the ischemic myocardium, prefer-
ably as a percentage of the left ventricle. It is also im-
portant that there is a consensus among physicians
interpreting MPS images regarding the amount of the
ischemic myocardium.
In this study we wanted to investigate 1) the inter-
observer variability for the extent of reversible perfusion
defects reported by different physicians in nuclear medi-
cine, 2) the variability for the reversible perfusion defects
obtained from different software tools, 3) the differences
between the assessments made by the physicians and the
different software packages and 4) if the inter-observer
variability is reduced when the physicians are provided
with a computerized suggestion of the delineation of the
reversible perfusion defects.
Methods
Patients and MPS protocol
The study was approved by the local research ethics
committee at Lund University and complies with the
Declaration of Helsinki.
Twenty-five patients who underwent MPS in Malmö,
Sweden January-February 2006 were included. The patients
were chosen in a consecutive manner based on the final
report, and only patients who where regarded as ischemic
were included. 16 of the patients were male; 9 were stressed
using maximal exercise test and 16 using Adenosine; mean
age was 71 ± 8.5 years; mean ejection fraction 57 ± 11%;
mean end-diastolic volume 139 ± 48 ml; 9 patients got
the diagnosis acute coronary syndrome after the MPS
(follow-up until 2010). According to the final report, 22
patients had single-vessel disease, 2 had multi-vessel
disease and 1 had suspected multi-vessel disease.
The MPS studies were performed according to clinical
routine, using a 2-day gated stress/gated rest 99mTc-tetrofos-
min protocol, starting with an injection of 600 MBq 99mTc-
tetrofosmin at stress. Patients were stressed using either
maximal exercise on an ergometer or a pharmacological
test with adenosine. The exercise test was continued for atleast 1 min after the injection of the tracer and the adeno-
sine infusion for at least 2 min after the injection of the
tracer. This examination was followed by a rest study with
injection of 600 MBq 99mTc-tetrofosmin.
Stress and rest acquisition began 60 min after the end of
the injection of 99mTc-tetrofosmin. Images were obtained
according to established clinical protocols, using single
photon emission computed tomography over 180° ellip-
tical, autocontour rotations from the 45° right anterior
oblique position, with a dual-head gamma camera, e.cam
(Siemens AG Medical Solutions, Erlangen, Germany).
Patients were imaged in the supine position. A low energy
high-resolution collimator and a zoom factor of 1.0 were
used. We obtained 64 (32 views per camera) projections
in a 128 × 128 matrix, with an acquisition time of 20 s
per projection. Stress images were gated to the electrocar-
diogram using 8 frames per cardiac cycle. No automatic
motion-correction program was applied; instead the
acquisition was repeated if motion was detected. Tomo-
graphic reconstruction and calculation of short and long
axis slice images were performed using e.soft (Siemens
AG Medical Solutions, Erlangen, Germany). Images were
reconstructed with filtered back-projection. A 2D Butter-
worth pre-reconstruction filter was used with cut-off
frequency of 0.45 Nyquist frequency, order 5.
Evaluations made by physicians
Eleven physicians in nuclear medicine from 8 different
hospitals in 4 countries (Sweden, Denmark, Germany, and
Japan) were invited to participate. Two of the physicians
had 5 and 7 years of experience with interpreting MPS,
and the other physicians had 15-40 years of experience.
All cases were classified visually, and a custom display
software was developed for this purpose, allowing the
physicians to view non-attenuation corrected slice images
(short axis, horizontal and vertical long axis) of the rest
and stress studies, polar plots (rest, stress, rest-stress
differences, stress/rest ratio) and 3D-images. Colour scales
and contrast levels were adjustable. No quantitative results
from the software package were available during the
evaluation. The physicians were instructed to delineate
the ischemic area in the polar plot. They could add as
many ischemic areas as they wanted. The physicians were
informed that the 25 cases had the diagnosis “reversible
ischemia” according to the clinical report (in which all
available clinical data, stress test, MPS study, etc. were
considered) and the gender of the patient. No other infor-
mation was given to the physicians (i.e. no information
about known cardiac diseases, symptoms, electrocardio-
gram, stress test results, weight, etc.).
After at least two weeks, all physicians delineated the
reversible defects again. This time they were provided a
suggestion of the defect delineation by EXINI HeartTM
(EXINI Diagnostics AB, Sweden; EXINI), but otherwise
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physicians were able to adjust the delineation suggested
by EXINI, or they could remove the suggested delineation
and create a new delineation. The studies were presented
in a different randomized order, compared with the order
in the first evaluation. Originally, none of the software
packages had the feature for the physician to easily adjust
a proposed delineation of a perfusion defect. We therefore
developed that on the platform of EXINI and choose to
use EXINI as reference method in the paper.
Software packages
Four different software packages were compared; (EXINI
version 5.0beta [11], Emory Cardiac Toolbox version 3.0
(Emory University; ECT [12]), Quantitative Perfusion
SPECT version 4.0 (Cedars Sinai; QPS [13]), 4D-MSPECT
version 4.0 (Invia Medical Solutions; 4DM [14]). Summed
difference scores (SDS) were obtained from all 4 programs
and compared to the total possible score from 17 seg-
ments (% ischemic myocardium); called EXINI summed
difference % (SD%), ECT (SD%), QPS (SD%) and 4DM
(SD%) in this article. This approach was included based
on the study by Hachamovitch et al [3] and this measure-
ment takes into account both the extent and the severity
of the defects. The extent of the ischemic defects were also
obtained from the programs; called EXINI (extent), ECT
(extent), QPS (extent) and 4DM (extent) in this article.
These measurements also reflect the percentage ischemic
myocardium (extent/area), but are calculated using other
methods compared to the SD% method. This approach
was included due to the recommendations in revasculari-
zation guidelines [6].
Automatic delineation of ischemic regions by EXINI
The automatic delineation of defects in EXINI proceeds
in two stages. In stage one, defects in the stress image
are delineated. From a number of seed points extracted
from local intensity minima, deformable models of circular
topology based on the active contour framework [15] are
fit to the image based on edge and intensity information.
This produces a set of “stress defects” which may be either
reversible and/or irreversible. In a second phase, each stress
defect is analysed in order to find strictly reversible
sub-regions based on information from the difference
image. Regions which are contained inside the stress
defects and which exhibit high difference intensities are
delineated using a simple smoothing and thresholding
approach, producing a set of reversible “difference defects”.
This paper concerns difference defects only.
Statistical analysis
Descriptive statistics for continuous variables are given
as mean and standard deviation (SD) or median and
range. Inter-observer variability is expressed as intra-classcorrelation (ICC) with 95% confidence intervals (CI)
between observers as estimated from linear mixed model
analysis where patients and observers were entered as
random effects. For comparison between the different
programs and observers, linear mixed models were used
where program (one at a time) and observers were entered
as fixed effects and patients as random effects. For a
comparison within observers’ mean values between the
two occasions without and with EXINI, Wilcoxon’s signed
rank test was used. The level of statistical significance
was set at p < 0.05. Bland-Altman plots were created for
analysis of relationship between the evaluations made
by EXINI and the physicians, where EXINI was used as
reference method [16].
Results
Inter-observer variability for physicians
The median values obtained for each of the 11 physicians
for the extent of the ischemic defects varied between 8%
and 34%. For each of the 25 studies, there was a large vari-
ation in the values reported by the different physicians.
The median values and range reported by the physicians
for each patient are shown in the last column of Table 1.
Variability between programs
The median values for the amount of ischemic area de-
tected by the different programs were 16% (range 0-59%)
for EXINI (extent), 13% (4-34%) for EXINI (SD%), 11%
(0-37%) for ECT (extent), 7% (0-26%) for ECT (SD%), 9%
(0-37%) for QPS (extent), 9% (0-35%) for QPS (SD%),
14% (0-61%) for 4DM (extent) and 12% (0-40%) for 4DM
(SD%). There was a considerable variation in the reported
amount of ischemic myocardium between the different
programs for the 25 patients (Table 1). Table 2 shows
the differences in mean ischemic area for the different
software packages compared to EXINI (extent). The
differences between EXINI (extent) and 4DM (SD%),
QPS (extent), QPS (SD%), and ECT (SD%) were found
to be significant (Table 2).
Comparison between software packages and physicians
Table 3 shows the differences in mean ischemic extent
values between the different physicians and the different
programs. The only physician that had <5 percentage
points differences between his/her evaluation and all of
the software packages was physician #H. Two physicians
(# C and D) had 5-10 percentage points larger ischemic
areas compared to all programs. These physicians were
located at the same hospital. Four physicians (# E, F, I
and J) had at least 10 percentage points larger ischemic
areas compared to all programs. These physicians were
located at three different hospitals in two countries. For
each program, the differences between the program and
at least one of the physicians were <2 percentage points.
Table 2 Differences in mean ischemic area between EXINI
and the other software packages
EXINI (extent) vs: Differences in
mean ischemic area
P-value Mean ischemic
area ± SD (%)
EXINI (SD%) −2.4 0.75 14.7 (± 8.2)
4DM (extent) −0.4 0.99 16.6 (± 13.1)
4DM (SD%) −5.6 0.023 11.4 (± 8.6)
ECT (extent) −4.4 0.12 12.5 (± 10.4)
ECT (SD%) −8.3 <0.001 8.8 (± 6.7)
QPS (extent) −5.3 0.036 11.7 (± 9.4)
QPS (SD%) −7.3 <0.001 9.7 (± 7.7)
The right columns shows mean ischemic area ± SD (%) of the respective
software packages.
EXINI (extent): extent (%) of ischemic defect.
EXINI (SD%): amount (%) of ischemic defect based on 5-point/
17-segment model.
Table 1 The amount ischemic myocardium (%), extent and SD%, obtained by the different programs for the 25 patients
Patient # EXINI EXINI ECT ECT QPS QPS 4DM 4DM Physicians
(extent) (SD%) (extent) (SD%) (extent) (SD%) (extent) (SD%)
1 27 16 3 6 15 3 14 6 26 (8-65)
2 0 6 0 0 0 0 0 0 6 (1-25)
3 9 7 3 7 7 4 2 3 14 (6-22)
4 19 13 18 7 24 19 15 7 23 (15-34)
5 8 10 14 15 2 3 7 3 25 (3-34)
6 21 24 37 26 37 35 61 40 27 (12-41)
7 4 15 1 1 5 4 5 15 10 (4-29)
8 0 6 17 7 6 10 24 12 6 (0-22)
9 17 16 16 10 18 12 25 12 24 (14-31)
10 17 10 10 1 20 13 3 3 17 (4-31)
11 26 18 7 6 9 9 19 13 25 (2-43)
12 3 7 4 6 8 7 13 9 7 (2-17)
13 22 22 15 6 15 15 29 24 24 (15-41)
14 59 34 12 15 0 0 14 13 54 (27-74)
15 9 10 32 16 9 9 22 16 16 (2-32)
16 0 9 3 6 5 6 12 12 12 (0-26)
17 16 13 11 7 4 3 10 6 30 (10-42)
18 14 10 10 3 5 9 11 10 28 (11-43)
19 43 32 26 22 32 19 35 18 43 (24-66)
20 11 9 6 10 10 12 9 6 14 (3-22)
21 38 24 34 21 21 19 34 22 46 (17-61)
22 34 26 15 0 9 10 17 16 38 (14-73)
23 7 4 3 6 14 6 9 3 7 (3-24)
24 5 7 5 4 4 3 8 3 9 (1-29)
25 16 18 12 9 13 12 17 13 22 (9-36)
Mean 17.0 14.7 12.5 8.8 11.7 9.7 16.6 11.4
±SD 14.6 8.2 10.4 6.9 9.4 7.7 13.1 8.6
Median extent values (and range) obtained from the 11 physicians for each patient (without suggestion of delineation from EXINI) are given as a reference.
EXINI (extent): extent (%) of ischemic defect.
EXINI (SD%): amount (%) of ischemic defect based on 5-point/17-segment model.
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in interpreting MPS.
Comparison of extent values obtained by physicians
without and with computerized suggestion
For all 25 patients, mean extent obtained from EXINI
was 17.0% (SD ± 14.6%). Mean extent for all physicians
was 22.6% (± 15.6%) for the first delineation, and 19.1%
(± 14.9%) for the second evaluation, where the physicians
were provided computerized suggestion of the delinea-
tion by EXINI. The difference was statistically significant
(p = 0.002). ICC for physicians increased from 0.56 (CI
0.41-0.72) for the first delineation to 0.81 (CI 0.71-0.90)
for the second. SD between physicians was 7.8 for the first
delineation and 5.9 for the second. The difference between
the physicians and EXINI was smaller when the physicians
Table 3 Differences in mean extent values between each software package and each physician
Physician EXINI (extent) EXINI (SD%) 4DM (extent) 4DM (SD%) ECT (extent) ECT (SD%) QPS (extent) QPS (SD%)
A 4.2 6.5 4.6 9.8 8.6 12.5 9.5 11.5
B −0.1 2.2 0.3 5.5 4.3 8.2 5.2 7.2
C 7.4 9.8 7.8 13.0 11.9 15.8 12.8 14.8
D 7.2 9.6 7.6 12.8 11.7 15.6 12.6 14.6
E 11.2 13.6 11.7 16.9 15.7 19.6 16.6 18.6
F 12.6 14.9 13.0 18.2 17.0 20.9 17.9 19.9
G −2.1 0.2 −1.8 3.4 2.3 6.2 3.2 5.2
H −3.4 −1.1 −3.1 2.1 1.0 4.8 1.8 3.8
I 12.6 14.9 13.0 18.2 17.0 20.9 17.9 19.9
J 19.1 21.4 19.5 24.7 23.6 27.4 24.4 26.4
K −7.0 −4.6 −6.6 −1.4 −2.6 1.3 −1.7 0.3
EXINI (extent): extent (%) of ischemic defect.
EXINI (SD%): amount (%) of ischemic defect based on 5-point/17-segment model.
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except for two physicians, who had a very small deviation
from EXINI also for the first delineation. Table 4 shows
the differences in mean extent between each physician and
EXINI, without and with suggestion by EXINI. Figure 1
shows the delineations made by the 11 physicians and
by EXINI for patient #12 without and with suggestions
by EXINI. Figure 2 shows the relationship between the
evaluation made by EXINI and the physicians (first
evaluation and the evaluation with suggestion by EXINI).
As seen in the figure, the variability among the physicians
varied for small, medium-sized and large ischemic areas.
Figure 2A and 2B show that the variability for the reported
ischemic areas decreased when the physicians where
provided with suggestion by EXINI. Figure 2C shows that
for most patients and physicians, the ischemic area wasTable 4 Differences in mean extent values between each
physician and EXINI, without and with suggested
delineation of the defect made by EXINI
Physician First evaluation P-value Evaluation
with suggestion
P-value
A 4.2 0.025 3.3 0.018
B −0.1 0.95 0.8 0.54
C 7.4 <0.0001 3.9 0.0049
D 7.2 <0.0001 0.4 0.79
E 11.3 <0.0001 0.9 0.52
F 12.6 <0.0001 3.1 0.027
G −2.2 0.25 0.1 0.95
H −3.5 0.063 −3.5 0.011
I 12.6 <0.0001 4.4 0.0016
J 19.1 <0.0001 12.5 <0.0001
K −7.0 0.0002 −3.0 0.031
Mean extent value for EXINI was 17.0%.reduced between the first and the second delineation,
but for some cases, the area was increased.
Discussion
In this study, we found that the inter-observer variability
for the delineation of ischemia was considerable when
both regarding different physicians and different software
packages. We also found that the inter-observer variability
decreased when the physicians were provided with a
suggested delineation of the ischemic defects by EXINI.
The results are of value when considering the new rec-
ommendation made by the European Society of Cardiology
regarding revascularization: patients with stable angina
and ischemic amount of myocardium >10% should receive
revascularization, whereas patients with ischemic myocar-
dium <10% should receive only medical treatment [6].
Therefore, quantitative analysis of ischemic area is needed
to determine the therapeutic strategy for patients with
ischemic heart disease. But how can the physician inter-
preting the MPS images decide on the amount of ischemic
myocardium when inter-observer variability among physi-
cians and software packages is large? The recommenda-
tion was based on studies by Hachamovitch et al [3,5],
where the authors found that in the setting of no or
mild amounts of inducible ischemia, patients undergoing
medical therapy had a survival advantage over patients
undergoing revascularization. These two lines intersected
at a value of ≈ 10% to 12.5% myocardium ischemic, above
which the survival benefit for revascularization over med-
ical therapy increased as a function of increasing amounts
of inducible ischemia. As seen in Figure 2, the variability
among the physicians varied for small, medium-sized and
large ischemic areas.
It is well known that SSS, summed rest scores (SRS)
and SDS differ between different programs. Guner et al
[7] compared the diagnostic performances of three
Figure 1 The delineations of the ischemic area made by the physicians and by EXINI for one of the patients. The upper row shows the
stress (a) and rest (b) polar plots as well as the difference rest-stress plot (c). The second row shows the delineation made by EXINI (d), the delineations
made by the 11 physicians without (e) and with (f) suggestion of the delineation provided by EXINI for stress polar plots. The third and forth rows
show the same delineations for rest polar plots (g, h, i) and difference rest-stress plots (j, k, l). The physicians were able to choose between stress,
rest or difference polar plots for their delineations.
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disease by 201Tl-MPS. They found that the diagnostic
performances of the programs to detect coronary artery
disease were similar. However, there were differences
in the quantitative values produced by the programs.
The differences in SDS between different programs
were significant (p < 0.0001). The highest correlation
was between 4DM and QPS (r = 0.68), and the lowest
was between ECT and QPS (r = 0.41). Wolak et al [8]
concluded that there were differences in myocardial
perfusion quantification, diagnostic performance, and
degree or automation of three software packages with
correlations between SSS for the three different software
packages evaluated ranging from r = 0.68 to r = 0.84.
Svensson et al [9] also investigated the quantification of
reversible perfusion defects by three different software
packages. They found that widely used software packages
commonly differ in their quantification of myocardialperfusion defects and conclude that the interpreting
physician should be aware of these differences when
using scoring systems.
Not only do the scoring values differ between different
software tools, there is also the risk of obtaining scores
in areas that are not believed to be ischemic (for example
can a patient get many scores of 1 in several areas of the
myocardium). The method of delineation of defects by
EXINI mimics the physicians’ way to delineate. It is also
easier to show the referring physician (often a cardiologist)
the extent of the defects rather than scoring values. One
should remember, however, that the recommendation of
10% is based on studies using scoring values and not
defect extents. Such studies are needed before incorp-
orating the method into clinical routine.
Despite the possible obstacles to provide a percentage
of ischemic myocardium to the referring cardiologist,
our study has also shown a possible solution. When the
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Figure 2 The relationship between the evaluations made by EXINI (extent) and the physicians, shown as Bland Altman plots. The left
diagram shows the relationship between EXINI and the first evaluation by the physicians (A). “First A-K” on the y axis represents first delineations
for the physicians (A-K). The middle diagram shows the relationship between EXINI and the evaluation by the physicians when they were provided
with a suggestion by EXINI (B). “With A-K” on the y axis represents the second delineation (with suggestion by EXINI) for the physicians (A-K). The
third diagram shows the relationship between the first and second (“with”) delineations made by the physicians (C). The solid line represents
mean value, and the heavy dotted lines represent ±1.96 SD. For diagram A and B, the thin dotted diagonal line represents the limit of maximum
possible difference (i.e. no value is possible below this line). The twenty-five colours represent the 25 different patients and the 11 symbols represent
the 11 physicians (A-K).
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the defect, the inter-observer variability decreased. Thus,
a program where the physicians easily can adjust the
suggested delineation could serve as a tool to make the
estimated ischemic amount more standardized. Such a
program could, beside standardization, also be used for
the training of young doctors.
One advantage for the present study is the relatively
large number of physicians involved as well as that the
physicians were from several hospitals and countries.
Typically, studies involving inter-observer variability
include only a few physicians, often from the same depart-
ment, which tend to decrease inter-observer variability.
Thus, the present study shows a “truer” variability in eval-
uations made by different physicians.
The findings of the present study should be considered
in the light of some limitations. In order to find enough
physicians willing to participate in the study, a limited
number of patients were included. However, it is of greater
importance to include several physicians and from dif-
ferent departments/countries. Also, we were not able to
verify the evaluations made by the physicians and software
packages with an independent reference technique. The
physicians did not have any background data regarding
the patients, no stress test result, and no information
about ejection fraction, left ventricular volumes or transient
ischemic dilation. It is possible that the ischemic delinea-
tions differ from the ones reported here if such information
would have been provided.
Conclusion
There was a large variability in the estimated ischemic
defect size obtained both from different physicians andfrom different software packages. When the physicians
were provided with a suggested delineation obtained by
EXINI, the inter-observer variability decreased. Physi-
cians should be aware of the large differences between
both different physicians and different software packages
when giving the amount of ischemic myocardium to the
referring physician.Competing interests
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